U.S. Court of Appeals for the Federal Circuit, 2020

Medicinova, Inc. v. Genzyme Corporation

Medicinova, Inc. v. Genzyme Corporation
U.S. Court of Appeals for the Federal Circuit · Decided December 14, 2020

Medicinova, Inc. v. Genzyme Corporation

Opinion

Case: 20-1064 Document: 70 Page: 1 Filed: 12/14/2020

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ MEDICINOVA, INC., A DELAWARE CORPORATION, Plaintiff-Appellant v. GENZYME CORPORATION, A MASSACHUSETTS CORPORATION, Defendant-Appellee ______________________ 2020-1064 ______________________ Appeal from the United States District Court for the Southern District of California in No. 3:14-cv-02513-JLS- KSC, Judge Janis L. Sammartino. ______________________ JUDGMENT ______________________ BRUCE G. CHAPMAN, Sheppard, Mullin, Richter & Hampton LLP, Los Angeles, CA, argued for plaintiff-appel- lant. Also represented by DON PELTO, Washington, DC; MATTHEW G. HALGREN, MARK GERARD RACKERS, San Diego, CA.

FRANCIS DIGIOVANNI, Faegre Drinker Biddle & Reath LLP, Wilmington, DE, argued for defendant-appellee. Also Case: 20-1064 Document: 70 Page: 2 Filed: 12/14/2020

represented by MICHAEL CURT LAMBERT, THATCHER A.

RAHMEIER; RABIYA KADER, Sanofi, Bridgewater, NJ. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (DYK, BRYSON, and O’MALLEY, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

December 14, 2020 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Case-law data current through December 31, 2025. Source: CourtListener bulk data.